Segment Reporting (Details) $ in Thousands	3 Months Ended
	Mar. 31, 2026 USD ($) segment	Mar. 31, 2025 USD ($)
Segment Reporting Information [Line Items]
Number of operating segments | segment	1
Number of reportable segments | segment	1
Revenue	$ 1,294	$ 858
Less: Significant segment expenses
Net loss	(18,331)	(12,433)
R&D
Segment Reporting Information [Line Items]
Revenue	1,294	858
Less: Significant segment expenses
Personnel-related expenses	5,875	5,187
Clinical and preclinical expenses	4,631	4,479
Facilities-related and overhead	1,793	1,976
Professional and consulting fees	1,471	1,601
Corporate expenses	340	581
Travel and entertainment	255	134
Plus: Other segment (loss) income	(5,260)	667
Net loss	$ (18,331)	$ (12,433)